Clinical trial
Utility, Acceptability and Applicability of a Nucleic Acid Amplification Test (NAAT) in Comparison With Syndromic Approach in the Management of Sexually Transmitted Diseases at Mulago National Referral Hospital in Uganda
NCT05994495 is registered in ClinicalTrials.gov with Riccardo Serraino as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Utility, Acceptability and Applicability of a Nucleic Acid Amplification Test (NAAT) in Comparison With Syndromic Approach in the Management of Sexually Transmitted Diseases at Mulago National Referral Hospital in Uganda
- Lead sponsor
- Riccardo Serraino
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 15, 2024
- Completion date
- March 30, 2025
- Enrollment
- 220 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.